Qingyu Liang

No. 155 Nanjing North Street, Heping District
Shenyang, 110001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

LILRB3 inhibition reverses immunosuppression in glioma: a nanoparticle-based therapeutic strategy.

LILRB3 inhibition reverses immunosuppression in glioma: a nanoparticle-based therapeutic strategy.

Journal: Journal of nanobiotechnology

Published: November 10, 2025

Profiling hypoxia signaling reveals a lncRNA signature contributing to immunosuppression in high-grade glioma.

Profiling hypoxia signaling reveals a lncRNA signature contributing to immunosuppression in high-grade glioma.

Journal: Frontiers in immunology

Published: July 27, 2024

Single-cell RNA sequencing and multiple bioinformatics methods to identify the immunity and ferroptosis-related biomarkers of SARS-CoV-2 infections to ischemic stroke.

Single-cell RNA sequencing and multiple bioinformatics methods to identify the immunity and ferroptosis-related biomarkers of SARS-CoV-2 infections to ischemic stroke.

Journal: Aging

Published: May 23, 2023

Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rate.

Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rate.

Journal: Communications biology

Published: November 19, 2022

Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma.

Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma.

Journal: PeerJ

Published: July 16, 2021

Establishment of tumor inflammasome clusters with distinct immunogenomic landscape aids immunotherapy.

Establishment of tumor inflammasome clusters with distinct immunogenomic landscape aids immunotherapy.

Journal: Theranostics

Published: May 26, 2021

Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner.

Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner.

Journal: Oncogene

Published: May 04, 2021

Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma.

Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma.

Journal: Journal of translational medicine

Published: April 14, 2020

Long non-coding RNA, HOTAIRM1, promotes glioma malignancy by forming a ceRNA network.

Long non-coding RNA, HOTAIRM1, promotes glioma malignancy by forming a ceRNA network.

Journal: Aging

Published: April 30, 2019

Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.

Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.

Journal: Journal of cellular biochemistry

Published: November 27, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026